Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 4:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 553–576 of 619 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Oral Supplement Clear all

Conditions: Activity-Related Knee Discomfort, Joint Discomfort, Functional Joint Pain, Functional Knee Pain, Knee Acute and Chronic Pain
Interventions: NT-II™ (240 mg), NT-II™ 480 mg, Glucosamine/Chondroitin; Dietary Supplement
Lead sponsor: Hofseth Biocare ASA; Industry
Eligibility: 20 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Exercise
Interventions: beetroot and anthocyanin, beetroot and placebo; Other
Lead sponsor: Loma Linda University; Other
Eligibility: 21 Years to 35 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Head Injury, Carotenoids
Interventions: Vision Edge Pro, Placebo; Drug · Other
Lead sponsor: Penn State University; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Lymphoma, B-Cell
Interventions: Pralatrexate, Vitamin B12, Folic Acid; Drug · Dietary Supplement
Lead sponsor: Spectrum Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 11
States / cities: Beverly Hills, California • Post Falls, Idaho • Chicago, Illinois + 8 more

Conditions: Obstructive Sleep Apnea
Interventions: Oral appliance, Oxygen, Oral appliance plus oxygen, No treatment; Device · Drug · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 21 Years to 79 Years
Enrollment: 41 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Alcoholic Hepatitis
Interventions: Anakinra and Zinc, Prednisone, Placebos; Drug
Lead sponsor: Indiana University; Other
Eligibility: 21 Years and older
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 10
States / cities: Phoenix, Arizona • Jacksonville, Florida • Indianapolis, Indiana + 7 more

Conditions: Asthma
Interventions: MCT, Clazakizumab, Broncho-Vaxom, Imatinib Mesylate, Cavosonstat, Placebo; Drug · Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 12 Years and older
Enrollment: 950 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 29
States / cities: Scottsdale, Arizona • Tucson, Arizona • Sacramento, California + 17 more

Conditions: Iron Deficiency (Without Anemia)
Interventions: Liquid Placebo Supplementation, Liquid Iron Supplement (Blood Builder ®); Dietary Supplement
Lead sponsor: Applied Science & Performance Institute; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 95 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Degenerative Intervertebral Discs, Sciatic Radiculopathy, Low Back Pain
Interventions: Eplerenone 50 Mg Tab, Placebo Oral Tablet; Drug
Lead sponsor: University of Cincinnati; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 2
States / cities: Cincinnati, Ohio • West Chester, Ohio

Conditions: Posttraumatic Stress Disorder
Interventions: Midomafetamine HCl, Lactose placebo pill, Therapy; Drug · Behavioral
Lead sponsor: Resilient Pharmaceuticals; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2010
U.S. locations: 1
States / cities: Mt. Pleasant, South Carolina

Conditions: Healthy
Interventions: Placebo, Dietary Supplement with Active Ingredient Blend; Dietary Supplement
Lead sponsor: Olly, PBC; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Advanced Cancers
Interventions: Surface-Controlled Water Soluble Curcumin, Surface-Controlled Water Soluble Curcumin MTD; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 13 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Peanut Allergy
Interventions: Prebiotic, Placebo; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 4 Years to 17 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Chicago, Illinois • Hyde Park, Illinois

Conditions: Hematologic Malignancy, Myeloid Malignancy
Interventions: Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG), Cyclosporine, Cyclophosphamide, Fludarabine, Methotrexate, Total Body Irradiation (radiation treatment), Bone marrow infusion, Busulfan, Thiotepa; Drug · Radiation
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 12 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: End Stage Renal Disease
Interventions: nutritional supplement, recombinant human growth hormone (rcGH), exercise; Dietary Supplement · Drug · Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1998 – 2006
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Autism Spectrum Disorder
Interventions: LCPUFA Oil Supplement, Canola Oil Placebo; Drug · Dietary Supplement
Lead sponsor: Sarah Keim; Other
Eligibility: 2 Years to 6 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Stem Cell
Interventions: Enteral nutrition (EN), Standard care parenteral nutrition (PN); Dietary Supplement · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Hair Loss, Hair Thinning
Interventions: Oral Nutraceutical Supplement, Placebo; Dietary Supplement
Lead sponsor: DeNova Research; Other
Eligibility: 21 Years to 45 Years · Male only
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Metastatic Cancer, Prostate Cancer
Interventions: zoledronic acid, placebo, androgen deprivation therapy, GnRH agonist, Calcium supplement, Vitamin D; Drug · Other · Dietary Supplement
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older · Male only
Enrollment: 645 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 238
States / cities: Mobile, Alabama • Fort Smith, Arkansas • Little Rock, Arkansas + 159 more

Conditions: Inflammatory Bowel Disease
Interventions: Vitamin D; Dietary Supplement
Lead sponsor: Penn State University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: Hershey, Pennsylvania • University Park, Pennsylvania

Conditions: Skin Abnormalities
Interventions: Tea, Serum, Moisturizer; Dietary Supplement · Other
Lead sponsor: Integrative Skin Science and Research; Industry
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Common Variable Immunodeficiency, Interstitial Lung Disease Due to Systemic Disease
Interventions: Fisetin, Placebo; Drug
Lead sponsor: Avni Joshi; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Diabetes Mellitus, Type 2
Interventions: Balance oral nutritional drink - control, Balance oral nutritional drink - test; Other
Lead sponsor: Société des Produits Nestlé (SPN); Industry
Eligibility: 20 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Tustin, California

Conditions: Multiple Sclerosis
Interventions: N-acetyl Cysteine; Dietary Supplement
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

NT-II™ Collagen for Joint Discomfort and Function

The Effects of Dietary Nitric Oxide and Anthocyanins on Anaerobic Exercise Performance

Carotenoids for Collision Athletes

Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea

Trial of Anakinra (Plus Zinc) or Prednisone in Patients With Severe Alcoholic Hepatitis

PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) Network Study

Efficacy of a Low Dose, Oral, Liquid Iron Supplement on Restoring Inadequate Blood Iron to Normal Levels

Eplerenone as a Supplement to Epidural Steroid Injections

MDMA-Assisted Psychotherapy in People With Posttraumatic Stress Disorder

Efficacy of Dietary Supplement in Subjects With Acid Reflux and/or Abdominal Bloating/Distention and GI Symptoms

Phase I Study of Surface-Controlled Water Soluble Curcumin (THERACURMIN CR-011L)

Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy

Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies.

Effects of Nutritional Supplementation on Protein and Energy Homeostasis in Malnourished Chronic Hemodialysis Patients

Fatty Acid Supplementation in Children With ASD

Safety, Tolerability, and Efficacy of Enteral Nutrition Versus Standard of Care Nutrition in Hematopoietic Stem Cell Transplant Patients: A Pilot Study

Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and Loss

Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases

Vitamin D Supplementation in Crohn's Patients

Topical and Oral Regimen for Skin Health

Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency

Glycemic Response in Adults with Diabetes

Physiological Effects of N-Acetyl Cysteine in Patients With Multiple Sclerosis